Skip to Main Content

Author Details

Jonathan L Wright
University of Washington Medical Center
2005
189
38
PMIDPaper TitleJournal TitlePublished Year
37806926Chronic Glucocorticoid Use and Risk for Advanced Prostate Cancer at Presentation: A SEER-Medicare Cohort Study.Clin Genitourin Cancer2024
35965206Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer.Eur Urol2023
37481462Racial and sex differences in tumor genomics in urothelial carcinoma.Urol Oncol2023
37609344Combinatorial genetic strategy accelerates the discovery of cancer genotype-phenotype associations.bioRxiv2023
37533407Pharmacological NF-κB inhibition decreases cisplatin chemoresistance in muscle-invasive bladder cancer and reduces cisplatin-induced toxicities.Mol Oncol2023
37084735Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression.Cancer Cell2023
37150667Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical Cystectomy.Clin Genitourin Cancer2023
37045706The Pursuit of Intravesical and Systemic Therapies in Non-muscle-invasive Bladder Cancer: Challenges and Opportunities.Eur Urol Oncol2023
37344281Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy Study.Clin Genitourin Cancer2023
36621991Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.J Urol2023
36907692Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17].Eur Urol2023
36710146A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer.Clin Genitourin Cancer2023
36931981Development and validation of a prognostic nomogram for overall and disease-specific survival in patients with sarcomatoid urothelial carcinoma.Urol Oncol2023
36795962Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.J Urol2023
34074558Prehabilitation Exercise Before Urologic Cancer Surgery: A Systematic and Interdisciplinary Review.Eur Urol2022
35445202Aggressive Prostate Cancer at Presentation Following Solid Organ Transplantation.Eur Urol Open Sci2022
35437583Methylation Subtypes of Primary Prostate Cancer Predict Poor Prognosis.Cancer Epidemiol Biomarkers Prev2022
37145718Naloxegol versus Alvimopan for Enhancing Postoperative Recovery following Radical Cystectomy for Bladder Cancer.Urol Pract2022
36601043Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis.Eur Urol Open Sci2022
36561732Effects of acupuncture to decrease adverse events in patients with high-risk non-muscle invasive bladder cancer receiving induction intravesical BCG therapy: Study protocol for a randomized, controlled pilot and feasibility study.Contemp Clin Trials Commun2022
36169695Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.World J Urol2022
35948037NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.J Natl Compr Canc Netw2022
36155169Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.Clin Genitourin Cancer2022
36183417Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer: Results From an Administrative Dataset.Alzheimer Dis Assoc Disord2022
35101380Sarcomatoid Urothelial Carcinoma: A Population-Based Study of Clinicopathologic Characteristics and Survival Outcomes.Clin Genitourin Cancer2022
34853071Prostate Cancer Risk Stratification via Nondestructive 3D Pathology with Deep Learning-Assisted Gland Analysis.Cancer Res2022
35181282Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54].Eur Urol Focus2022
35078711Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.Clin Genitourin Cancer2022
34643090Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy.J Urol2022
34597472Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.BJU Int2022
32981193Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.BJU Int2021
35387424A Prospective Study of a Resorbable Intravesical Fiducial Marker for Bladder Cancer Radiation Therapy.Adv Radiat Oncol2021
33898656Underutilization of Surgical Standard of Care for Insured Men with Invasive Penile Cancer.Urol Pract2021
33785257Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab.Eur Urol2021
33755225Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high-risk localized prostate cancer.Prostate2021
33633154A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture.Sci Rep2021
33551249Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy.Urol Oncol2021
34032633mRNA translation is a therapeutic vulnerability necessary for bladder epithelial transformation.JCI Insight2021
34370078Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.World J Urol2021
33373709Social and Clinical Correlates of Neoadjuvant Chemotherapy in Medicare Beneficiaries With Muscle Invasive Bladder Cancer From 2004-2015.Urology2021
33160889Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program.Clin Genitourin Cancer2021
33152179Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis.BJU Int2021
32771446Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium.Eur Urol Focus2021
31462701The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study.Prostate Cancer Prostatic Dis2020
34109262Plasmacytoid urothelial carcinoma: response to chemotherapy and oncologic outcomes.Bladder Cancer2020
32057595Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer.Urol Oncol2020
32073346Editorial Comment.J Urol2020
32071439Copy number alterations are associated with metastatic-lethal progression in prostate cancer.Prostate Cancer Prostatic Dis2020
31676278The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.Urol Oncol2020
33225061Application of Health Technology Assessment (HTA) to Evaluate New Laboratory Tests in a Health System: A Case Study of Bladder Cancer Testing.Acad Pathol2020
  • 1 - 50 of 189

Recommended Authors

Giovanni Motterle
Mayo Clinic
Career Start Year 2017
Number of shared co-authors 5
Saum Ghodoussipour
Rutgers Cancer Institute of New Jersey
Career Start Year 2016
Number of shared co-authors 1
Jamil S Syed
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 1
Adam B Weiner
Northwestern University Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 12
Simpa S Salami
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 15
Ridwan Alam
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 7
Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 3
Adam Kinnaird
University of Alberta
Career Start Year 2007
Number of shared co-authors 3
Alastair D Lamb
University of Oxford
Career Start Year 2007
Number of shared co-authors 11
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Career Start Year 2007
Number of shared co-authors 2
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 6
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Career Start Year 2004
Number of shared co-authors 17
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 1
Robert Jeffrey Karnes
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 44
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1999
Number of shared co-authors 8
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 14
Stephen J Freedland
Cedars-Sinai Medical Center
Career Start Year 1996
Number of shared co-authors 40
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 15
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 18
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 8
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 9
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 2
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 25
Neil E Fleshner
University of Toronto
Career Start Year 1989
Number of shared co-authors 38
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 27
Mark Frydenberg
Monash University
Career Start Year 1988
Number of shared co-authors 16
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 19
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 9
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 31
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 51

Collaborators

Daniel W Lin
Co-authored papers 64
John L Gore
University of Washington School of Medicine
Co-authored papers 50
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers 35
Evan Y Yu
University of Washington and Fred Hutchinson Cancer Research Center
Co-authored papers 31
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 21
Suzanne Kolb
Fred Hutchinson Cancer Research Center
Co-authored papers 17
Elaine A Ostrander
National Cancer Institute
Co-authored papers 17
Lawrence D True
University of Washington School of Medicine
Co-authored papers 16
Todd M Morgan
University of Michigan ann arbor
Co-authored papers 13
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 13
Philippe E Spiess
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 13
Colin P Dinney
The University of Texas MD Anderson Cancer Center
Co-authored papers 12
Jian-Bing Fan
Nanfang Hospital and Basic Medical College, Southern Medical University
Co-authored papers 10
Heather H Cheng
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 10
Michiel S van der Heijden
the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
Co-authored papers 8
Marina Bibikova
Departments of Bioinformatics and Clinical Genomics, Illumina Inc.
Co-authored papers 8
Elahe A Mostaghel
University of Washington
Co-authored papers 7
Elai Davicioni
Veracyte Inc.
Co-authored papers 7
Marian L Neuhouser
Fred Hutchinson Cancer Center
Co-authored papers 6
Brandy Klotzle
Departments of Bioinformatics and Clinical Genomics, Illumina Inc.
Co-authored papers 6
James Y Dai
Fred Hutchinson Cancer Center
Co-authored papers 5
Neeraj Agarwal
Co-authored papers 5
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Co-authored papers 5
Dean A Troyer
Eastern Virginia Medical School
Co-authored papers 5
Avery B Nathens
University of Toronto.
Co-authored papers 5
Alvin M Matsumoto
Co-authored papers 4
Xiaoyu Wang
Fred Hutchison Cancer Center
Co-authored papers 4
Stephen R Plymate
University of Washington
Co-authored papers 4
Steven B Zeliadt
VA Puget Sound Healthcare System
Co-authored papers 3
Jure Murgic
University Hospital Center Sestre Milosrdnice
Co-authored papers 3
Release 1.2